Table of Contents

2019-2024 Global Paclitaxel Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Paclitaxel Consumption 2014-2024
  • 2.1.2 Paclitaxel Consumption CAGR by Region
• 2.2 Paclitaxel Segment by Type
  • 2.2.1 Natural Paclitaxel API
  • 2.2.2 Semi-synthetic Paclitaxel API
• 2.3 Paclitaxel Consumption by Type
  • 2.3.1 Global Paclitaxel Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Paclitaxel Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Paclitaxel Sale Price by Type (2014-2019)
• 2.4 Paclitaxel Segment by Application
  • 2.4.1 Ovarian Cancer
  • 2.4.2 Cervical Cancer
  • 2.4.3 Breast Cancer
  • 2.4.4 Other
• 2.5 Paclitaxel Consumption by Application
  • 2.5.1 Global Paclitaxel Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Paclitaxel Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Paclitaxel Sale Price by Application (2014-2019)

3 Global Paclitaxel by Players

• 3.1 Global Paclitaxel Sales Market Share by Players
  • 3.1.1 Global Paclitaxel Sales by Players (2017-2019)
  • 3.1.2 Global Paclitaxel Sales Market Share by Players (2017-2019)
• 3.2 Global Paclitaxel Revenue Market Share by Players
  • 3.2.1 Global Paclitaxel Revenue by Players (2017-2019)
  • 3.2.2 Global Paclitaxel Revenue Market Share by Players (2017-2019)
• 3.3 Global Paclitaxel Sale Price by Players
• 3.4 Global Paclitaxel Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Paclitaxel Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Paclitaxel Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Paclitaxel by Regions

• 4.1 Paclitaxel by Regions
  • 4.1.1 Global Paclitaxel Consumption by Regions
  • 4.1.2 Global Paclitaxel Value by Regions
• 4.2 Americas Paclitaxel Consumption Growth
• 4.3 APAC Paclitaxel Consumption Growth
• 4.4 Europe Paclitaxel Consumption Growth
• 4.5 Middle East & Africa Paclitaxel Consumption Growth

5 Americas

• 5.1 Americas Paclitaxel Consumption by Countries
  • 5.1.1 Americas Paclitaxel Consumption by Countries (2014-2019)
  • 5.1.2 Americas Paclitaxel Value by Countries (2014-2019)
• 5.2 Americas Paclitaxel Consumption by Type
• 5.3 Americas Paclitaxel Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Paclitaxel Consumption by Countries
  • 6.1.1 APAC Paclitaxel Consumption by Countries (2014-2019)
  • 6.1.2 APAC Paclitaxel Value by Countries (2014-2019)
• 6.2 APAC Paclitaxel Consumption by Type
• 6.3 APAC Paclitaxel Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Paclitaxel by Countries
  • 7.1.1 Europe Paclitaxel Consumption by Countries (2014-2019)
  • 7.1.2 Europe Paclitaxel Value by Countries (2014-2019)
• 7.2 Europe Paclitaxel Consumption by Type
• 7.3 Europe Paclitaxel Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Paclitaxel by Countries
  • 8.1.1 Middle East & Africa Paclitaxel Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Paclitaxel Value by Countries (2014-2019)
• 8.2 Middle East & Africa Paclitaxel Consumption by Type
• 8.3 Middle East & Africa Paclitaxel Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Paclitaxel Distributors
• 10.3 Paclitaxel Customer

11 Global Paclitaxel Market Forecast

• 11.1 Global Paclitaxel Consumption Forecast (2019-2024)
• 11.2 Global Paclitaxel Forecast by Regions
  • 11.2.1 Global Paclitaxel Forecast by Regions (2019-2024)
  • 11.2.2 Global Paclitaxel Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Paclitaxel Forecast by Type
• 11.8 Global Paclitaxel Forecast by Application

12 Key Players Analysis

• 12.1 Phyton
  • 12.1.1 Company Details
  • 12.1.2 Paclitaxel Product Offered
  • 12.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Phyton News
• 12.2 ScinoPharm
  • 12.2.1 Company Details
  • 12.2.2 Paclitaxel Product Offered
  • 12.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 ScinoPharm News
• 12.3 Novasep
  • 12.3.1 Company Details
  • 12.3.2 Paclitaxel Product Offered
  • 12.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Novasep News
• 12.4 Samyang
  • 12.4.1 Company Details
  • 12.4.2 Paclitaxel Product Offered
  • 12.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Samyang News
• 12.5 Polymed
  • 12.5.1 Company Details
  • 12.5.2 Paclitaxel Product Offered
  • 12.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Polymed News
• 12.6 TAPI (Teva)
  • 12.6.1 Company Details
  • 12.6.2 Paclitaxel Product Offered
  • 12.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 TAPI (Teva) News
• 12.7 Fresenius-kabi
  • 12.7.1 Company Details
  • 12.7.2 Paclitaxel Product Offered
  • 12.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Fresenius-kabi News
• 12.8 Huiang biopharma
  • 12.8.1 Company Details
  • 12.8.2 Paclitaxel Product Offered
  • 12.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Huiang biopharma News
• 12.9 Southpharma
  • 12.9.1 Company Details
  • 12.9.2 Paclitaxel Product Offered
  • 12.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Southpharma News
• 12.10 Yunnan Hande
  • 12.10.1 Company Details
  • 12.10.2 Paclitaxel Product Offered
  • 12.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Yunnan Hande News
• 12.11 Hainan Yew Pharm
• 12.12 Jiangsu Yew Biotechnology

13 Research Findings and Conclusion

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.

According to this study, over the next five years the Paclitaxel market will register a 9.0% CAGR in terms of revenue, the global market size will reach US$ 140 million by 2024, from US$ 90 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Paclitaxel business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel market by product type, application, key manufacturers and key regions and countries.

This study considers the Paclitaxel value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Paclitaxel consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Paclitaxel market by identifying its various subsegments.
Focuses on the key global Paclitaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paclitaxel with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Paclitaxel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.